New Coverage
Provided by: Set Up E-mail Alerts For New Coverage » RSS Feed For New Coverage »
Oppenheimer initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $12.72 yesterday, with a 52 week range of $6.72-$14.06.
Maxim Group initiates coverage on Tekmira Pharma (NASDAQ: TKMR) with a Buy. PT $7.00.
For an analyst ratings summary and ratings history on Tekmira Pharma click here. For more ratings news on Tekmira Pharma click here.
Shares of Tekmira Pharma closed at $4.80 yesterday, with a 52 week range of $1.86-$6.78.
Maxim Group initiated coverage on Agenus Inc. (NASDAQ: AGEN) with a Buy rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Agenus Inc. click here. For more ratings news on Agenus Inc. click here.
Shares of Agenus Inc. closed at $3.75 yesterday, with a 52 week range of $3.37-$5.47.
UBS initiates coverage on ING Groep NV (NYSE: ING) with a Buy. PT $12.67.
For an analyst ratings summary and ratings history on ING Groep NV click here. For more ratings news on ING Groep NV click here.
Shares of ING Groep NV closed at $9.30 yesterday, with a 52 week range of $5.59-$10.47.
(Updated - June 18, 2013 11:23 AM EDT)
Canaccord Genuity initiated coverage on T-Mobile US, (NYSE: TMUS) with a Hold rating and a price target of $22.00. Analyst Greg Miller views shares as fully valued.
"Although we feel the company is a highly attractive takeover candidate for whichever company does not manage to acquire Sprint and/or Clearwire (either Softbank or Dish Networks), absent such an event the stock appears fully valued. Adjusted for differences in accounting of handset subsidies for its Value Plans, T-Mobile US trades at a slightly lower valuation than its peers. However, we believe the discount is warranted given the differences in scale, growth trajectory and margin profile relative to other national carriers," he said.
For an analyst ratings summary and ratings history on T-Mobile US, click here. For more ratings news on T-Mobile US, click here.
Shares of T-Mobile US, closed at $22.32 yesterday, with a 52 week range of $16.01-$22.97.
More New Coverage
View Older Stories-
UPDATE: UBS Starts Insmed (INSM) at Buy
-
Lake Street Capital Markets Starts Callidus Software (CALD) at Buy
-
Compass Point Starts Brown & Brown (BRO) at Buy
-
Compass Point Starts Arthur J. Gallagher (AJG) at Buy
-
Wells Fargo Starts Quintiles (Q) at Outperform
-
Goldman Sachs Starts Quintiles (Q) at Neutral
-
Deutsche Bank Starts Quintiles (Q) at Buy
-
Pacific Crest Starts LinkedIn (LNKD) at Outperform
-
Wells Fargo Starts StealthGas (GASS) at Outperform
-
JMP Securities Starts RCS Capital (RCAP) at Market Outperform
-
Stifel Nicolaus Starts Huntington Ingalls (HII) at Hold
-
Raymond James Starts American Residential Properties (ARPI) at Outperform
-
Baird Starts Quintiles (Q) at Neutral
-
BofA/Merrill Lynch Starts Quintiles (Q) at Buy
-
Morgan Stanley Starts Quintiles (Q) at Overweight
-
Piper Jaffray Starts Quintiles (Q) at Overweight
-
JPMorgan Starts Quintiles (Q) at Overweight
-
Sterne Agee Starts Quintiles (Q) at Underperform
-
Needham & Company Starts Fusion-io (FIO) at Buy, Sentiment/Estimate at Trough
-
Williams Financial Group Starts Ply Gem Holdings (PGEM) at Buy; Great Way to Play Housing
-
Cantor Fitzgerald Starts CRH plc (CRH) at Hold
-
Longbow Research Starts Greif Inc. (GEF) at Neutral
-
Jefferies Starts Quintiles (Q) at Hold
-
UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
-
WallachBeth Capital Starts Momenta Pharmaceuticals (MNTA) at Buy
-
BNP Paribas Starts Vipshop Holdings (VIPS) at Buy
-
UPDATE: UBS Starts Insmed (INSM) at Buy
-
Wedbush Starts Intuitive Surgical (ISRG) at Outperform
-
UPDATE: Global Equities Starts Tesla Motors (TSLA) at Overweight
-
William Blair Starts Portola Pharmaceuticals (PTLA) at Outperform
-
Maxim Group Starts Aruba Networks (ARUN) at Buy
-
Goldman Sachs Starts ChannelAdvisor (ECOM) at Buy
-
Raymond James Starts ChannelAdvisor (ECOM) at Outperform
-
Pacific Crest Starts ChannelAdvisor (ECOM) at Outperform
-
Iberia Capital Starts QEP Resources (QEP) at Outperform
-
Needham & Company Starts ChannelAdvisor (ECOM) at Buy
-
Wells Fargo Starts U.S. Silica Holdings (SLCA) at Outperform
-
Deutsche Bank Starts IHS Inc. (IHS) at Hold
-
Tudor Pickering Starts Marathon Oil (MRO) at Accumulate
-
Cowen Starts Teradata (TDC) at Underperform
-
Axiom Capital Starts Joy Global (JOY) at Sell
-
JPMorgan Starts Blackstone Mortgage Trust (BXMT) at Overweight
-
WallachBeth Capital Starts Biolase (BIOL) at Buy
-
Cowen Starts Sangamo BioSciences (SGMO) at Outperform
-
Baird Starts T-Mobile US (TMUS) at Neutral
-
Morgan Stanley Starts Portola Pharmaceuticals (PTLA) at Overweight
-
Brinson Patrick Starts Vical (VICL) at Market Outperform
-
RBC Capital Starts EQT Midstream Partners, LP (EQM) at Outperform
-
Citi Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Sterne Agee Starts Walker & Dunlop (WD) at Neutral
